A novel vascular smooth muscle chymase is upregulated in hypertensive rats

Caiying Guo, Haisong Ju, Debbie Leung, Hamid Massaeli, Mingda Shi, Marlene Rabinovitch

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

While greater than 80% of angiotensin II (Ang II) formation in the human heart and greater than 60% in arteries appears to result from chymase activity, no cardiovascular cell-expressed chymase has been previously reported. We now describe the cloning of a full-length cDNA encoding a novel chymase from rat vascular smooth muscle cells. The cDNA encompasses 953 nucleotides, encodes 247 amino acids, and exhibits 74% and 80% homology in amino acid sequence to rat mast cell chymase I and II, respectively. Southern blot analysis indicates that the rat vascular chymase is encoded by a separate gene. This chymase was induced in hypertrophied rat pulmonary arteries, with 11-fold and 8-fold higher chymase mRNA levels in aortic and pulmonary artery smooth muscle cells from spontaneously hypertensive than in corresponding tissues from normotensive rats. We assayed the activity of the endogenous enzyme and of a recombinant, epitope-tagged chymase in transfected smooth muscle cells and showed that Ang II production from Ang I can be inhibited with chymostatin, but not EDTA or captopril. Spontaneously hypertensive rats show elevated chymase expression and increased chymostatin-inhibitable angiotensin-converting activity, suggesting a possible role for this novel enzyme in the pathophysiology of hypertension.

Original languageEnglish
Pages (from-to)703-715
Number of pages13
JournalJournal of Clinical Investigation
Volume107
Issue number6
DOIs
Publication statusPublished - 1 Jan 2001
Externally publishedYes

Fingerprint

Chymases
Vascular Smooth Muscle
Smooth Muscle Myocytes
Angiotensin II
Pulmonary Artery
Complementary DNA
Amino Acid Sequence Homology
Captopril
Angiotensins
Inbred SHR Rats
Enzymes
Southern Blotting
Mast Cells
Edetic Acid
Blood Vessels
Organism Cloning
Epitopes
Nucleotides
Arteries
Hypertension

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A novel vascular smooth muscle chymase is upregulated in hypertensive rats. / Guo, Caiying; Ju, Haisong; Leung, Debbie; Massaeli, Hamid; Shi, Mingda; Rabinovitch, Marlene.

In: Journal of Clinical Investigation, Vol. 107, No. 6, 01.01.2001, p. 703-715.

Research output: Contribution to journalArticle

Guo, Caiying ; Ju, Haisong ; Leung, Debbie ; Massaeli, Hamid ; Shi, Mingda ; Rabinovitch, Marlene. / A novel vascular smooth muscle chymase is upregulated in hypertensive rats. In: Journal of Clinical Investigation. 2001 ; Vol. 107, No. 6. pp. 703-715.
@article{080406176c6b4c9c9c00d05fd34c548a,
title = "A novel vascular smooth muscle chymase is upregulated in hypertensive rats",
abstract = "While greater than 80{\%} of angiotensin II (Ang II) formation in the human heart and greater than 60{\%} in arteries appears to result from chymase activity, no cardiovascular cell-expressed chymase has been previously reported. We now describe the cloning of a full-length cDNA encoding a novel chymase from rat vascular smooth muscle cells. The cDNA encompasses 953 nucleotides, encodes 247 amino acids, and exhibits 74{\%} and 80{\%} homology in amino acid sequence to rat mast cell chymase I and II, respectively. Southern blot analysis indicates that the rat vascular chymase is encoded by a separate gene. This chymase was induced in hypertrophied rat pulmonary arteries, with 11-fold and 8-fold higher chymase mRNA levels in aortic and pulmonary artery smooth muscle cells from spontaneously hypertensive than in corresponding tissues from normotensive rats. We assayed the activity of the endogenous enzyme and of a recombinant, epitope-tagged chymase in transfected smooth muscle cells and showed that Ang II production from Ang I can be inhibited with chymostatin, but not EDTA or captopril. Spontaneously hypertensive rats show elevated chymase expression and increased chymostatin-inhibitable angiotensin-converting activity, suggesting a possible role for this novel enzyme in the pathophysiology of hypertension.",
author = "Caiying Guo and Haisong Ju and Debbie Leung and Hamid Massaeli and Mingda Shi and Marlene Rabinovitch",
year = "2001",
month = "1",
day = "1",
doi = "10.1172/JCI9997",
language = "English",
volume = "107",
pages = "703--715",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - A novel vascular smooth muscle chymase is upregulated in hypertensive rats

AU - Guo, Caiying

AU - Ju, Haisong

AU - Leung, Debbie

AU - Massaeli, Hamid

AU - Shi, Mingda

AU - Rabinovitch, Marlene

PY - 2001/1/1

Y1 - 2001/1/1

N2 - While greater than 80% of angiotensin II (Ang II) formation in the human heart and greater than 60% in arteries appears to result from chymase activity, no cardiovascular cell-expressed chymase has been previously reported. We now describe the cloning of a full-length cDNA encoding a novel chymase from rat vascular smooth muscle cells. The cDNA encompasses 953 nucleotides, encodes 247 amino acids, and exhibits 74% and 80% homology in amino acid sequence to rat mast cell chymase I and II, respectively. Southern blot analysis indicates that the rat vascular chymase is encoded by a separate gene. This chymase was induced in hypertrophied rat pulmonary arteries, with 11-fold and 8-fold higher chymase mRNA levels in aortic and pulmonary artery smooth muscle cells from spontaneously hypertensive than in corresponding tissues from normotensive rats. We assayed the activity of the endogenous enzyme and of a recombinant, epitope-tagged chymase in transfected smooth muscle cells and showed that Ang II production from Ang I can be inhibited with chymostatin, but not EDTA or captopril. Spontaneously hypertensive rats show elevated chymase expression and increased chymostatin-inhibitable angiotensin-converting activity, suggesting a possible role for this novel enzyme in the pathophysiology of hypertension.

AB - While greater than 80% of angiotensin II (Ang II) formation in the human heart and greater than 60% in arteries appears to result from chymase activity, no cardiovascular cell-expressed chymase has been previously reported. We now describe the cloning of a full-length cDNA encoding a novel chymase from rat vascular smooth muscle cells. The cDNA encompasses 953 nucleotides, encodes 247 amino acids, and exhibits 74% and 80% homology in amino acid sequence to rat mast cell chymase I and II, respectively. Southern blot analysis indicates that the rat vascular chymase is encoded by a separate gene. This chymase was induced in hypertrophied rat pulmonary arteries, with 11-fold and 8-fold higher chymase mRNA levels in aortic and pulmonary artery smooth muscle cells from spontaneously hypertensive than in corresponding tissues from normotensive rats. We assayed the activity of the endogenous enzyme and of a recombinant, epitope-tagged chymase in transfected smooth muscle cells and showed that Ang II production from Ang I can be inhibited with chymostatin, but not EDTA or captopril. Spontaneously hypertensive rats show elevated chymase expression and increased chymostatin-inhibitable angiotensin-converting activity, suggesting a possible role for this novel enzyme in the pathophysiology of hypertension.

UR - http://www.scopus.com/inward/record.url?scp=0035107611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035107611&partnerID=8YFLogxK

U2 - 10.1172/JCI9997

DO - 10.1172/JCI9997

M3 - Article

VL - 107

SP - 703

EP - 715

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -